Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Excessive hair growth is much more common in Chinese women with PCOS than in the general population.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Women with PCOS have lower amylin levels, which are not related to their body weight.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.